FIELD: medicine.
SUBSTANCE: present invention relates to medicine, namely to endocrinology, and concerns prevention and/or treatment of insulin resistance. For that effective amount of Eubacterium hallii is introduced in form of pharmaceutical, food or fodder composition.
EFFECT: method provides effective correction of insulin resistance due to higher level of Eubacterium hallii in small intestine.
10 cl, 3 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| EUBACTERIUM HALLII CULTIVATION AND PRESERVATION METHOD | 2017 |
|
RU2737398C1 |
| COMPOSITIONS AND METHODS FOR PREVENTING AND/OR TREATING VITAMIN B12 DEFICIENCY | 2017 |
|
RU2730870C2 |
| FECAL MICROBIOTA COMPOSITION FOR USE IN REDUCING TREATMENT-INDUCED INFLAMMATION | 2019 |
|
RU2816462C2 |
| KIT FOR PREDICTION OR DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE AND A METHOD OF DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE | 2020 |
|
RU2800086C1 |
| AUXILIARY DIAGNOSTIC METHOD FOR USE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME USING CORRECTIVE DIET OR FECAL MICROBIOTA TRANSPLANTATION | 2017 |
|
RU2762266C1 |
| METHODS FOR MODULATING INTESTINAL MICROBIOTA | 2017 |
|
RU2738265C2 |
| METHOD FOR DETERMINING RESPONSE OF A PATIENT DIAGNOSED WITH SKIN MELANOMA TO ANTI-PD1-THERAPY | 2020 |
|
RU2771080C2 |
| COMPOSITIONS AND METHODS | 2014 |
|
RU2664479C2 |
| SYNBIOTIC COMPOSITION FOR DISORDER PREVENTION | 2018 |
|
RU2773458C2 |
| SPHINGOMYELIN AND INDIGESTIBLE CARBOHYDRATES USAGE FOR GUT MICROBIOTA NORMALISATION | 2008 |
|
RU2478309C2 |
